CANOPY GROWTH CORP (WEED.CA) Stock Fundamental Analysis
Canada - TSX:WEED - CA1380357048 - Common Stock
1.9 CAD
+0.05 (+2.7%)
Overall WEED gets a fundamental rating of 2 out of 10. We evaluated WEED against 31 industry peers in the Pharmaceuticals industry. WEED scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. WEED is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
WEED had negative earnings in the past year.
WEED had a negative operating cash flow in the past year.
WEED had negative earnings in each of the past 5 years.
WEED had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
WEED's Return On Assets of -56.65% is on the low side compared to the rest of the industry. WEED is outperformed by 78.13% of its industry peers.
Looking at the Return On Equity, with a value of -104.81%, WEED is doing worse than 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -56.65% | ||
| ROE | -104.81% | ||
| ROIC | N/A |
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
WEED has a Gross Margin of 27.83%. This is in the lower half of the industry: WEED underperforms 62.50% of its industry peers.
The Profit Margin and Operating Margin are not available for WEED so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 27.83% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
WEED does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for WEED has been increased compared to 1 year ago.
The number of shares outstanding for WEED has been reduced compared to 5 years ago.
WEED has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -11.69, we must say that WEED is in the distress zone and has some risk of bankruptcy.
WEED's Altman-Z score of -11.69 is on the low side compared to the rest of the industry. WEED is outperformed by 87.50% of its industry peers.
A Debt/Equity ratio of 0.63 indicates that WEED is somewhat dependend on debt financing.
The Debt to Equity ratio of WEED (0.63) is worse than 65.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -11.69 |
ROIC/WACCN/A
WACC10.17%
2.3 Liquidity
A Current Ratio of 3.07 indicates that WEED has no problem at all paying its short term obligations.
WEED's Current ratio of 3.07 is amongst the best of the industry. WEED outperforms 87.50% of its industry peers.
WEED has a Quick Ratio of 2.12. This indicates that WEED is financially healthy and has no problem in meeting its short term obligations.
WEED's Quick ratio of 2.12 is amongst the best of the industry. WEED outperforms 87.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.07 | ||
| Quick Ratio | 2.12 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 55.18% over the past year.
Looking at the last year, WEED shows a decrease in Revenue. The Revenue has decreased by -4.25% in the last year.
The Revenue has been decreasing by -7.57% on average over the past years.
EPS 1Y (TTM)55.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.25%
Revenue 1Y (TTM)-4.25%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%8.94%
3.2 Future
The Earnings Per Share is expected to grow by 15.29% on average over the next years. This is quite good.
WEED is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.24% yearly.
EPS Next Y87.72%
EPS Next 2Y39.4%
EPS Next 3Y25.31%
EPS Next 5Y15.29%
Revenue Next Year8.32%
Revenue Next 2Y5.98%
Revenue Next 3Y7.52%
Revenue Next 5Y7.24%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for WEED. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for WEED. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
WEED's earnings are expected to grow with 25.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.4%
EPS Next 3Y25.31%
5. Dividend
5.1 Amount
No dividends for WEED!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:WEED (10/24/2025, 7:00:00 PM)
1.9
+0.05 (+2.7%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners5.58%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap642.67M
Revenue(TTM)274.92M
Net Income(TTM)-512504000
Analysts46.15
Price Target3.77 (98.42%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-99.21%
Min EPS beat(2)-206.63%
Max EPS beat(2)8.22%
EPS beat(4)1
Avg EPS beat(4)-132.67%
Min EPS beat(4)-231.12%
Max EPS beat(4)8.22%
EPS beat(8)1
Avg EPS beat(8)-186.16%
EPS beat(12)2
Avg EPS beat(12)-180.17%
EPS beat(16)4
Avg EPS beat(16)-164.19%
Revenue beat(2)2
Avg Revenue beat(2)8.61%
Min Revenue beat(2)7.65%
Max Revenue beat(2)9.57%
Revenue beat(4)3
Avg Revenue beat(4)5.74%
Min Revenue beat(4)-0.3%
Max Revenue beat(4)9.57%
Revenue beat(8)5
Avg Revenue beat(8)3.48%
Revenue beat(12)7
Avg Revenue beat(12)1.93%
Revenue beat(16)8
Avg Revenue beat(16)-0.87%
PT rev (1m)0%
PT rev (3m)25.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)17.62%
EPS NY rev (1m)0%
EPS NY rev (3m)-17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)8.84%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2.34 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.31 | ||
| P/tB | 1.8 | ||
| EV/EBITDA | N/A |
EPS(TTM)-4.28
EYN/A
EPS(NY)-0.32
Fwd EYN/A
FCF(TTM)-0.39
FCFYN/A
OCF(TTM)-0.37
OCFYN/A
SpS0.81
BVpS1.45
TBVpS1.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -56.65% | ||
| ROE | -104.81% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 27.83% | ||
| FCFM | N/A |
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 21.16% | ||
| Cap/Sales | 3.21% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.07 | ||
| Quick Ratio | 2.12 | ||
| Altman-Z | -11.69 |
F-Score5
WACC10.17%
ROIC/WACCN/A
Cap/Depr(3y)15.39%
Cap/Depr(5y)45.04%
Cap/Sales(3y)2.72%
Cap/Sales(5y)9.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.25%
EPS Next Y87.72%
EPS Next 2Y39.4%
EPS Next 3Y25.31%
EPS Next 5Y15.29%
Revenue 1Y (TTM)-4.25%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%8.94%
Revenue Next Year8.32%
Revenue Next 2Y5.98%
Revenue Next 3Y7.52%
Revenue Next 5Y7.24%
EBIT growth 1Y47.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year86.74%
EBIT Next 3Y33.01%
EBIT Next 5Y21.01%
FCF growth 1Y76.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y78.03%
OCF growth 3YN/A
OCF growth 5YN/A
CANOPY GROWTH CORP / WEED.CA FAQ
Can you provide the ChartMill fundamental rating for CANOPY GROWTH CORP?
ChartMill assigns a fundamental rating of 2 / 10 to WEED.CA.
What is the valuation status for WEED stock?
ChartMill assigns a valuation rating of 1 / 10 to CANOPY GROWTH CORP (WEED.CA). This can be considered as Overvalued.
How profitable is CANOPY GROWTH CORP (WEED.CA) stock?
CANOPY GROWTH CORP (WEED.CA) has a profitability rating of 0 / 10.